Aklief - (0.005% Cream)

Generic Name	Trifarotene	Innovator	Galderma
Dosage	0.005% Cream	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	Less Than 5	Tentative Approvals	None
Final Approvals	None	Generic Launches	None
Indication	AKLIEF Cream is a retinoid indicated for the topical treatment of acne vulgaris in patients 9 years of age and older.
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
****	*** \ *********	-**-	******* ***** ********* ************	****	******* *** **** *** *** ****
**** ******	*** \ *********	-**-	*******	****	******* *** **** *** *** ****

Chronology Of Events